Liquid biopsies in lung cancer: the new ambrosia of researchers

C Rolfo, M Castiglia, D Hong, R Alessandro… - … et Biophysica Acta (BBA …, 2014 - Elsevier
In the last decades the approach to cancer patient management has been deeply
revolutionized. We are moving from a “one-fits-all” strategy to the “personalized medicine” …

Functional dissection of astrocyte-secreted proteins: Implications in brain health and diseases

MK Jha, JH Kim, GJ Song, WH Lee, IK Lee… - Progress in …, 2018 - Elsevier
Astrocytes, which are homeostatic cells of the central nervous system (CNS), display
remarkable heterogeneity in their morphology and function. Besides their physical and …

Microglia promote glioblastoma via mTOR‐mediated immunosuppression of the tumour microenvironment

AA Dumas, N Pomella, G Rosser, L Guglielmi… - The EMBO …, 2020 - embopress.org
Tumour‐associated microglia/macrophages (TAM) are the most numerous non‐neoplastic
populations in the tumour microenvironment in glioblastoma multiforme (GBM), the most …

Global secretome analysis identifies novel mediators of bone metastasis

MA Blanco, G LeRoy, Z Khan, M Alečković, BM Zee… - Cell research, 2012 - nature.com
Bone is the one of the most common sites of distant metastasis of solid tumors. Secreted
proteins are known to influence pathological interactions between metastatic cancer cells …

Inflammatory cytokines, interleukin-1 beta and tumor necrosis factor-alpha, upregulated in glioblastoma multiforme, raise the levels of CRYAB in exosomes secreted …

RA Kore, EC Abraham - Biochemical and biophysical research …, 2014 - Elsevier
In the brain, levels of inflammatory cytokines, interleukin-1 beta (IL-1β) and tumor necrosis
factor-alpha (TNF-α), are elevated under traumatic brain injury, neuroinflammatory …

Plasma-derived extracellular vesicles reveal galectin-3 binding protein as potential biomarker for early detection of glioma

R Rana, K Chauhan, P Gautam, M Kulkarni… - Frontiers in …, 2021 - frontiersin.org
Gliomas are the most common type of the malignant brain tumor, which arise from glial cells.
They make up about 40% of all primary brain tumors and around 70% of all primary …

Glioblastoma-secreted soluble CD44 activates tau pathology in the brain

S Lim, D Kim, S Ju, S Shin, I Cho, SH Park… - … & molecular medicine, 2018 - nature.com
During aggressive tumor growth and migration, glioblastoma cells secrete diverse
molecules and adhesion proteins to the extracellular matrix. Yet, the biochemical effects of …

SILAC‐based quantitative proteomic analysis of gastric cancer secretome

A Marimuthu, Y Subbannayya… - PROTEOMICS …, 2013 - Wiley Online Library
Purpose Gastric cancer is a commonly occurring cancer in A sia and one of the leading
causes of cancer deaths. However, there is no reliable blood‐based screening test for this …

Review of methods for determination of total protein and peptide concentration in biological samples

CV Sapan, RL Lundblad - PROTEOMICS–Clinical Applications, 2015 - Wiley Online Library
Clinical proteomics can be defined as the use of proteomic technologies to identify and
measure biomarkers in fluids and tissues. The current work is intended to review various …

Interleukin-1-induced changes in the glioblastoma secretome suggest its role in tumor progression

L Tarassishin, J Lim, DB Weatherly, RH Angeletti… - Journal of …, 2014 - Elsevier
The tumor microenvironment including glial cells and their inflammatory products regulates
brain tumor development and progression. We have previously established that human …